Anna-Lina Herz

Post‐neoadjuvant assessment of tumour budding according to ITBCC subgroups delivers stage‐ and regression‐grade independent prognostic information in intestinal‐type gastric adenocarcinoma

W. Weichert, C. Denkert, A. Hapfelmeier, 2022, The journal of pathology. Clinical research.

Elevated microsatellite instability at selected tetranucleotide (EMAST) repeats in gastric cancer: a distinct microsatellite instability type with potential clinical impact?

W. Weichert, J. Slotta-Huspenina, A. Hapfelmeier, 2022, The journal of pathology. Clinical research.

Significant Tumor Regression after Neoadjuvant Chemotherapy in Gastric Cancer, but Poor Survival of the Patient? Role of MHC Class I Alterations

W. Weichert, J. Slotta-Huspenina, A. Hapfelmeier, 2023, Cancers.

S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinoma–final results of the randomized AIO MATEO phase II trial

F. Lordick, J. Trojan, R. Greil, 2023, ESMO Open.

Microsatellite instability and sex-specific differences of survival in gastric cancer after neoadjuvant chemotherapy without and with taxane: An observational study in real world patients

W. Weichert, J. Slotta-Huspenina, M. Gaida, 2023, Journal of Cancer Research and Clinical Oncology.